You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic pancreatic ductal adenocarcinoma (mPDAC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

RWE on mPDAC Long-term Survival After Treatment With Liposomal

Recruiting
  • Pancreatic Cancer Metastatic
    • Munich, Germany
      Klinikum der Universität München, - Anstalt des öffentlichen Rec
    Nov 24, 2023

    Pancreatic Cancer Trial in Munich, Heidelberg, Zürich (SBRT, SOC chemo)

    Recruiting
    • Pancreatic Cancer
    • SBRT
    • SOC chemotherapy
    • Munich, Bavaria, Germany
    • +2 more
    Apr 6, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Worldwide (NIS793, Nab-paclitaxel, Gemcitabine)

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Fayetteville, Arkansas
    • +122 more
    Jan 27, 2023

    Pancreatic Cancer Trial (TTX-030, nab-paclitaxel and gemcitabine, TTX-030, budigalimab, nab-paclitaxel and gemcitabine,

    Not yet recruiting
    • Pancreatic Cancer
    • TTX-030, nab-paclitaxel and gemcitabine
    • +2 more
    • (no location specified)
    Nov 3, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (BXCL701, Pembrolizumab)

    Not yet recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Washington, District of Columbia
      Georgetown Lombardi Comprehensive Cancer Center
    Jan 23, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • +12 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 30, 2022

    Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Washington, District of Columbia
      Lombardi Comprehensive Cancer Center, Georgetown University
    Apr 11, 2023

    PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

    Not yet recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
    • (no location specified)
    Jul 9, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Stage IV Pancreatic Cancer AJCC v8
    • Autologous Mesothelin-specific TCR-T Cells
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 31, 2023

    Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +3 more
    • Cholesterol metabolism disruption
    • Quebec city, Quebec, Canada
      CHU de Québec-Université Laval
    Oct 17, 2022

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Boston (other, diagnostic test, combination product)

    Not yet recruiting
    • Pancreatic Cancer
    • +4 more
    • Screening Blood Tests
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Nov 3, 2023

    Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +2 more
    • Enfortumab vedotin
    • Kansas City, Kansas
      University of Kansas Cancer Center
    Jun 23, 2023

    Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Durvalumab
    • Rintatolimod
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus MC
    Jun 23, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in United States (Relacorilant, 100 mg and 25 mg, Nab paclitaxel)

    Terminated
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Relacorilant, 100 mg and 25 mg
    • Nab paclitaxel
    • Scottsdale, Arizona
    • +17 more
    May 11, 2022

    Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Phoenix, Arizona
    • +5 more
    Dec 15, 2022

    Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease Trial in Baltimore (FOLFIRINOX chemo)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Oligometastatic Disease
    • FOLFIRINOX chemotherapy
    • Baltimore, Maryland
      Johns Hopkins Hospital
    Nov 2, 2023

    Minimal Residual Disease Using Multi-omics Approach

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
    • Shanghai, China
      Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
    Nov 29, 2023

    Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Washington, District of Columbia
      Lombardi Comprehensive Cancer Center, Georgetown University
    Aug 24, 2023

    Pancreatic Ductal Adenocarcinoma Trial in Miami (Trametinib, Ruxolitinib, Retifanlimab)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Miami, Florida
      University of Miami
    Jun 27, 2022

    Pancreatic Ductal Adenocarcinoma, Pain, Acute Trial in San Francisco (Ketamine, Meaning and Purpose therapy)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Pain, Acute
    • San Francisco, California
      University of California, San Francisco
    Oct 12, 2023

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen

    Recruiting
    • Pancreatic Cancer
    • +3 more
    • Bio-specimen Collection: Blood
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 21, 2023

    Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

    Not yet recruiting
    • Pancreatic Acinar Cell Carcinoma
    • +6 more
    • Nab paclitaxel
    • +5 more
    • (no location specified)
    Oct 30, 2023

    Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (Eryaspase,

    Active, not recruiting
    • Locally Advanced Pancreatic Ductal Adenocarcinoma
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Washington, District of Columbia
      Georgetown Lombardi Comprehensive Cancer Center
    Aug 3, 2022

    Metastatic Pancreatic Adenocarcinoma Trial in United States (Nivolumab (Cohort A), Ipilimumab (Cohort A and B),

    Active, not recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • Nivolumab (Cohort A)
    • +4 more
    • Los Angeles, California
    • +6 more
    Aug 8, 2022

    Pancreas Cancer Trial in Seoul (Vactosertib)

    Recruiting
    • Pancreas Cancer
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jun 13, 2022